The Rescue P4 dosage with low P4 results in pregnancy rates similar to patients with sufficient progesterone.

Published Date: 10 Mar 2023

Over the past decade, frozen embryo transfer (FET) has been increasingly used by infertility clinics today. Few years ago...

Read Full News

Latest News

Menstruation topic still stigmatized by younger generation in Spain, study finds

The menstrual taboo persists. This is the main conclusion of a pioneering macro-study in Spain involving more than 4,000 participants and led by the INGENIO Institute, a joint center of the Spanish National Research Council ...

Research team develops actionable tool to assess risk for premature births

Researchers at NYU and partners within the International Healthy Outcomes of Pregnancy for Everyone (HOPE) Consortium have developed a novel tool, the Preterm Birth Actionable Risk Index (PTB-ARIx), designed to identify pregnant ...

AHA: Study examines impact of adequate prenatal care for congenital heart disease

For cases of mild congenital heart defects (CHDs), more prenatal visits are associated with lower probability of delivery at a cardiac center, according to a study published online Nov. 9 in JAMA Network Open to coincide ...

Severe nausea during pregnancy and depression: Study reveals bidirectional association

A recent study conducted at the University of Turku in Finland showed that hyperemesis gravidarum, a severe form of nausea that occurs during pregnancy, is linked to depression. Women who experienced severe nausea were more ...

Common cesarean closure method linked to long-term complications, experts suggest change

The most common technique used for closing the uterus after a cesarean delivery causes so many long-term complications that it's time to question its use. That's the conclusion reached by two world-renowned specialists in ...

From post-partum depression to relationship woes: The importance of mental health after giving birth

"Postpartum depression" has been discussed as an identifiable, measurable, treatable disorder for 50 years now. Thresholds, scales, prevalence rates: everything seems clear, even reassuring.

Todays Updates

This Week on NeurologyLive® — November 24, 2025 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Positive Phase 3 OCEANIC-STROKE Data Position Asundexian for Upcoming FDA Submission Marco Meglio

Encouraging data from the OCEANIC-STROKE study suggest that asundexian may soon join the therapeutic landscape for secondary stroke prevention as Bayer advances toward submission.

Progress with Emerging TYK2 Inhibitors for Psoriasis, With Benjamin Lockshin, MD Benjamin Lockshin, MD, FAAD

Benjamin Locksin speaks in this interview about his session titled ‘Encapsulating Progress With New and Emerging TYK2 Inhibitors for Psoriasis.’

Discussing Zasocitinib and Other TYK2 Inhibitors for Psoriasis, With Ronald Vender, MD Ronald Vender, MD

After his sessions on TYK2 Inhibitors for psoriasis and on palmoplantar pustulosis, Vender discussed several key insights in this interview.

FDA Clears BrainsWay’s TMS Device for Adolescents with MDD Aged 15 to 21 Years

FDA Clears BrainsWay’s TMS Device for Adolescents with MDD Aged 15 to 21 Years

Adjunctive Perospirone Safe, Well-Tolerated for MDD in Phase 4 Trial

Adjunctive Perospirone Safe, Well-Tolerated for MDD in Phase 4 Trial

Otsuka Pharmaceuticals Submits NDA for Centanafadine to Treat ADHD in Children

Otsuka Pharmaceuticals Submits NDA for Centanafadine to Treat ADHD in Children

Todays Updates

This Week on NeurologyLive® — November 24, 2025 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Positive Phase 3 OCEANIC-STROKE Data Position Asundexian for Upcoming FDA Submission Marco Meglio

Encouraging data from the OCEANIC-STROKE study suggest that asundexian may soon join the therapeutic landscape for secondary stroke prevention as Bayer advances toward submission.

Progress with Emerging TYK2 Inhibitors for Psoriasis, With Benjamin Lockshin, MD Benjamin Lockshin, MD, FAAD

Benjamin Locksin speaks in this interview about his session titled ‘Encapsulating Progress With New and Emerging TYK2 Inhibitors for Psoriasis.’

Discussing Zasocitinib and Other TYK2 Inhibitors for Psoriasis, With Ronald Vender, MD Ronald Vender, MD

After his sessions on TYK2 Inhibitors for psoriasis and on palmoplantar pustulosis, Vender discussed several key insights in this interview.

FDA Clears BrainsWay’s TMS Device for Adolescents with MDD Aged 15 to 21 Years

FDA Clears BrainsWay’s TMS Device for Adolescents with MDD Aged 15 to 21 Years

Adjunctive Perospirone Safe, Well-Tolerated for MDD in Phase 4 Trial

Adjunctive Perospirone Safe, Well-Tolerated for MDD in Phase 4 Trial

Otsuka Pharmaceuticals Submits NDA for Centanafadine to Treat ADHD in Children

Otsuka Pharmaceuticals Submits NDA for Centanafadine to Treat ADHD in Children

Latest News

The menstrual taboo persists. This is the main conclusion of a pioneering macro-study in Spain involving more than 4,000 participants and led by the INGENIO Institute, a joint center of the Spanish National Research Council ...

Researchers at NYU and partners within the International Healthy Outcomes of Pregnancy for Everyone (HOPE) Consortium have developed a novel tool, the Preterm Birth Actionable Risk Index (PTB-ARIx), designed to identify pregnant ...

For cases of mild congenital heart defects (CHDs), more prenatal visits are associated with lower probability of delivery at a cardiac center, according to a study published online Nov. 9 in JAMA Network Open to coincide ...

A recent study conducted at the University of Turku in Finland showed that hyperemesis gravidarum, a severe form of nausea that occurs during pregnancy, is linked to depression. Women who experienced severe nausea were more ...

The most common technique used for closing the uterus after a cesarean delivery causes so many long-term complications that it's time to question its use. That's the conclusion reached by two world-renowned specialists in ...

"Postpartum depression" has been discussed as an identifiable, measurable, treatable disorder for 50 years now. Thresholds, scales, prevalence rates: everything seems clear, even reassuring.

News All Time

New study shows long-term effectiveness of HPV vaccine

A new study has confirmed that the human papillomavirus (HPV) vaccine provides strong and sustained protection against cervical disease that can develop into cancer.

Exercise reduces risk of common postpartum pelvic floor problems

Targeted pelvic floor muscle training in the first year postpartum significantly reduces the risk of two common pelvic floor disorders, according to a study that rewrites the longstanding narrative that these disorders are ...

Problems with regulating emotions during pregnancy may help predict perinatal depression

Around 1 in 5 mothers experience perinatal depression. This condition involves depressive episodes during pregnancy or just after birth—often with lasting effects on both mother and child.

Sugar–protein interactions, critical for placenta during early pregnancy, shed light on common complications

During the first weeks of pregnancy, the developing placenta in a mother's womb undergoes a dramatic change. Individual cells merge, forming a continuous barrier that will spend the next nine months ferrying oxygen and nutrients ...

The quiet collapse of America's reproductive health safety net

In late October, Maine Family Planning announced three rural clinics in northern Maine would close by month's end. These primary care and reproductive health clinics served about 800 patients, many uninsured or on Medicaid.

Meta-analysis evaluates effectiveness of various psychological therapies for perinatal depression

A systematic review and meta-analysis evaluated the effectiveness of psychological therapies for perinatal depression, the most prevalent maternal mental health disorder. The review, published in the Annals of Internal Medicine, ...

Wildfire smoke exposure during pregnancy linked to higher risk of preterm birth

About 10% of American babies are born prematurely. Birth before 37 weeks can lead to a cascade of health risks, both immediate and long-term, making prevention a vital tool for improving public health over generations.

Back pain during pregnancy is often dismissed as a passing discomfort—a nurse explains why it should be taken seriously

About half to three-quarters of expectant mothers experience pain during pregnancy that is largely untreated, contributing to preventable suffering and harm. Many mothers avoid medications and treatments during pregnancy ...

Researchers discuss gaps, obstacles and solutions for contraception

Contraception and family planning are vital aspects of sexual and reproductive health and rights. Despite major advances in modern contraception over the past 60 years, many gaps remain and the rate of unplanned pregnancies ...

COVID-19 during pregnancy linked to higher risk of neurodevelopmental disorders in children

Children born to mothers who had COVID-19 while pregnant face an elevated risk of developmental disorders by the time they turn 3 years old, including speech delays, autism, motor disorders, and other developmental delays, ...

Safeguarding fertility: Study investigates key hormone for women with cancer choosing fertility preservation

Newly diagnosed female cancer patients of reproductive age have a very short window for storing their eggs and embryos before starting cancer treatment. This is a process known as fertility preservation (FP), which protects ...

Breast cancer risk varies between different hormonal contraceptives, research reveals

Some common hormonal contraceptives are linked to a slightly higher risk of breast cancer than others. This is shown by a Swedish study from Uppsala University, in which researchers followed more than two million women and ...

Punitive drug laws may deter prenatal care and hospital-based delivery

States that explicitly criminalize prenatal drug use may unintentionally discourage pregnant people from seeking essential medical care, according to new research from Columbia University Mailman School of Public Health. ...

Highlighting key therapies that support women through high-risk pregnancies 

Joint research from Edith Cowan University (ECU) and the University of St. Augustine for Health Sciences, in the US, is shedding new light on the broader potential of psychosocial occupational therapy, revealing it can play ...

Study shows Australian preterm birth prevention program is working

New data has shown that an initiative to reduce preterm births in Australia has led to a significant decrease in rates of potentially harmful early birth and improved pregnancy outcomes for women across the country.

Vitamin D deficiency increases risk of complicated deliveries, finds study

A research team at Uppsala University has identified a clear link between osteomalacia—a form of bone softening commonly caused by vitamin D deficiency—and a fivefold increased risk of emergency cesarean sections or the ...

Recommended News For You

Urinary tract cancer prediction models with high sensitivity and specificity

Testosterone recovery linked to overall survival in high-risk prostate cancer

How to keep your prostate healthy and lower your risk of developing serious problems

PSMA PET Beats MRI in Prostate Cancer Staging Study

No increased risk of childhood cancer near UK nuclear sites, study finds

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

Results for Prostate Cancer Are Associated With PSA Nadir 6 Months After Primary RT.

Recommended Articles For You

Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms 

Driving Impact: Oncology Pharmaceutical Marketing Strategies in the USA 

Case Study: Advancing Preclinical Oncology Drug Development with Quantitative Systems Pharmacology 

Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Significant differences in breast cancer care still exist, but surgeons can change.

2.

A small rise in cancer was observed following the 1986 Chernobyl accident.

3.

Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management.

4.

Researchers use AI to monitor side effects of chemotherapy and support families dealing with pediatric cancer.

5.

AI catches one-third of interval breast cancers missed at screening

1.

The Predictive Power of Theranostics in Palliative Neuroendocrine Tumor Management

2.

Unleashing the Power of AI: A Systematic Review of Predictive Biomarker Discovery in Immuno-Oncology

3.

An Overview Of Leukemia Cutis: What It Is And How To Treat It

4.

Oncolytic Viruses in Breast Cancer: Unlocking Synergy with Novel Combination Therapies

5.

Advancing Cancer Care: Insights into Oncology Trials, Immunotherapy, and CAR-T Innovations

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I

2.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I

3.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

4.

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients

5.

Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot